Clinical Trials Logo

Substance Use Disorders clinical trials

View clinical trials related to Substance Use Disorders.

Filter by:

NCT ID: NCT01457872 Completed - Clinical trials for Substance Use Disorders

Malmö Treatment Referral and Intervention Study

MATRIS
Start date: October 2011
Phase: N/A
Study type: Interventional

This study aims to study and implement active referral of heroin users from a syringe exchange programme to evidence-based treatment for heroin addiction. Patients are randomized to either a strength-based case management intervention or a control group, while both groups receive referral to medical investigation for inclusion in substitution treatment for heroin addiction. The hypothesis is that syringe exchange can be used for referral to effective treatment, and that a strength-based intervention can increase the number of patients who are successfully referred and enter treatment.

NCT ID: NCT01431235 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders

Start date: August 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.

NCT ID: NCT01357577 Completed - PTSD Clinical Trials

Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs

CBT
Start date: January 1, 2013
Phase: N/A
Study type: Interventional

With this research, the investigators hope to learn if cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) works in people who have both PTSD and problems with drugs or alcohol. In the past, people who had problems with drugs and alcohol were not given treatment for their PTSD. It was believed that PTSD treatment would get in the way of their drug and alcohol treatment. Now the investigators believe that the PTSD symptoms may make it harder to avoid using drugs and alcohol, so the investigators want to see if people can get treatment for both problems at the same time. One hundred-sixty Veterans from 3 sites who have both PTSD and substance use disorders will be in the study. In order to know if the PTSD treatment is helpful, half of the Veterans in this study will receive PTSD treatment and half will continue to get their usual mental health and/or substance abuse treatment. Who gets which treatment will be decided by a random process. The investigators will then compare the 2 groups to see if there are differences in their PTSD symptoms.

NCT ID: NCT01356667 Terminated - Clinical trials for Substance Use Disorders

Drum-Assisted Therapy for Native Americans

Start date: September 2010
Phase: N/A
Study type: Interventional

Drum-Assisted Recovery Therapy for Native Americans (DARTNA) is an R-21 NIH/NCCAM-funded study aimed to complete the development and pilot a new substance abuse treatment protocol utilizing drumming for American Indians/Alaska Natives with substance use disorders. The study includes activities to complete the protocol, followed by a randomized-controlled clinical trial.

NCT ID: NCT01271413 Completed - Clinical trials for Substance Use Disorders

Cognitive Stimulation

Start date: December 2010
Phase: Phase 2
Study type: Interventional

This research is being done to learn if computer tasks that challenge the brain (cognitively stimulating tasks) can improve memory and other types of thinking. The study will compare the effects of different versions of the computer tasks. It also will compare the task performance of different groups of people.

NCT ID: NCT01237366 Completed - HIV Clinical Trials

Study Targeting Affect Regulation

STAR
Start date: September 2010
Phase: Phase 1/Phase 2
Study type: Interventional

This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who have sex with men (MSM). Following a baseline assessment, 56 participants will be randomized to receive either: 1) a 7-session intervention to address traumatic stress related to living with HIV/AIDS; or 2) a 7-session, attention-control condition. Follow-up assessments will be administered at 1 and 3 months post-randomization.

NCT ID: NCT01186315 Completed - Clinical trials for Posttraumatic Stress Disorder

Post-traumatic Stress Disorder (PTSD), Addiction, and Virtual Reality

Start date: December 2008
Phase: N/A
Study type: Interventional

Eligible veterans, National Guardsmen & Reservists with post-traumatic stress disorder (PTSD) and problems with addiction will be randomly assigned to one of two treatment conditions. All participants will undergo exposure therapy, a gold standard behavioral treatment for PTSD for 10 weeks. In addition to exposure therapy, some participants will be randomly assigned to receive (1) virtual reality (VR)-based exposure to cues for marijuana, cocaine, heroin, cigarette, and/or alcohol use, and (2) cellular phone-based reminders of learning (extinction reminders, or, ERs) to VR exposure (available 24 hours per day/7 days per week) to high-risk contexts for drug use. The main hypothesis is that those participants who receive exposure therapy + VR/ERs will demonstrate less substance use and lower PTSD symptoms during treatment, at post-treatment, and at follow-up than those participants who only receive exposure therapy. At study completion, a total of 123 subjects signed consent.

NCT ID: NCT01159535 Active, not recruiting - Clinical trials for Substance Use Disorders

Mindfulness Based Relapse Prevention: Efficacy and Mechanisms

MBRP
Start date: October 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol and other drug (AOD) use disorders in preventing AOD relapse compared to treatment as usual (TAU) offered in the community. The two cognitive-behavioral aftercare treatments are relapse prevention (RP) and Mindfulness-Based Relapse Prevention (MBRP), which integrates mindfulness meditation and RP aftercare components.

NCT ID: NCT01153594 Completed - Clinical trials for Substance Use Disorders

Early Re-Intervention Experiment 2

ERI2
Start date: February 2004
Phase: Phase 3
Study type: Interventional

The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.

NCT ID: NCT01148381 Recruiting - Healthy Volunteers Clinical Trials

Characterization of Phenotypic and Genotypic Regressors for Imaging

Start date: November 18, 2010
Phase:
Study type: Observational

The influence of genes on addictive and neuropsychiatric disorders is complex, especially given that multiple genes likely influence certain behaviors that are correlated with addiction. Researchers are interested in looking at the genetic information of individuals who are enrolled on National Institute for Drug Abuse studies to investigate specific genetic variants that may be related to substance abuse. Researchers will study the effects of genes on several aspects of thinking such as attention, memory, decision making, problem solving, learning, and emotional feelings, and investigate the ways in which genetic information affects addictive behaviors and substance abuse. In addition, researchers will study how genes may explain differences in imaging data in substance users. Objectives: - To collect genetic information for research on genetic aspects of addiction and substance abuse. Eligibility: - Adults age 18 or older - (1) healthy, non-drug-using nonsmokers, - (2) healthy smokers, - (3) healthy individuals dependent on other commonly abused drugs, and - (4) individuals with other psychiatric disorders. - Participants must be enrolled in another National Institute on Drug Abuse, Intramural Research Program imaging protocol. Design: - This study involves one to two visits to National Institute on Drug Abuse, Intramural Research Program that may be separate from the participant's current research protocol study visits or on the same day as those visits. - Participants will provide a blood sample and complete questionnaires about mood, memory, and learning. - Participants may also be asked to do a few tasks, such as playing computer games involving coin tosses and money management, or responding to questions on a computer screen.